Items where Author is "Catto, James W.F."
Number of items: 3.
Article
Erdafitinib in BCG-treated high risk non-muscle invasive bladder cancer. (2024)
James W.F. Catto,
Ben Tran,
Morgan Roupret,
Juergen E. Gschwend,
Yohann Loriot,
Hiroyuki Nishiyama,
Joan P. Redorta,
Siamak Daneshmand,
Syed A. Hussain,
Hernan J Cutuli,
Giuseppe Procopio,
Valentina Guadalupi,
Nikhil Vasdev,
Vahid Naini,
Lauren Crow,
Spyros Triantos,
Mahadi Baig
and
Gary D. Steinberg
Other
Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials. (2023)
Pramit Khetrapal,
Joanna Kae Ling Wong,
Wei Phin Tan,
Thiara Rupasinghe,
Wei Shen Tan,
Stephen Williams,
Stephen A. Boorjian,
Carl Wijburg,
Dipen J. Parekh,
Peter Wiklund,
Nikhil Vasdev,
Muhammad Shamim Khan,
Khurshid A Guru,
James W.F. Catto
and
John D Kelly
Phase 2 Study of the Efficacy and Safety of Erdafitinib in Patients With Bacillus Calmette-Guérin (BCG)-Unresponsive, High-Risk Non–Muscle-Invasive Bladder Cancer (HR-NMIBC) With FGFR3/2 Alterations (alt) in THOR-2: Cohort 2 Interim Analysis Results. (2023)
James W.F. Catto,
Ben Tran,
Viraj A. Master,
Morgan Roupret,
Geraldine Pignot,
Andrea Tubaro,
Nobuaki Shimizu,
Nikhil Vasdev,
Juergen Gschwend,
Yohann Loriot,
Hiyoyuki Nishiyama,
Joan Redorta,
Siamak Daneshmand,
Yuji Miura,
Vahid Naini,
Lauren Crow,
Spyros Triantos,
Mahadi Baig
and
Gary D. Steinberg